Edwards Lifesciences (EW) Stock: Buy, Sell, or Hold?
EW - Edwards Lifesciences Corp
$84.08
-2.69 (-3.10%)
▼
5d:
-6.35%
30d:
-9.64%
90d:
-1.96%
HOLD
MODERATE Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Oct 29, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 4, 2026 at $89.90 · last confirmed Sep 8, 2026
Strength: 7.0/10
Get Alerted When EW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EW shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: EW shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$125.55
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$77.96
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EW is currently trading at $84.08, which is considered oversold relative to its 30-day fair value range of $88.00 to $92.07. The stock's valuation (Forward PE: 25.7) is in line with its historical norms (26.4). Remarkably, the market is currently pricing in an annual earnings decline of 0.9% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EW is in a uptrend. The price is currently testing key support at $83.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $100.96 (+16.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EW is in a uptrend. The price is currently testing key support at $83.86. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.1% recently.
Market Sentiment: The stock scores a mixed 50/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $100.96 (+16.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$88.00 -
$92.07
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
72.4%
Protect Your Profits
Holding EW? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (50/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.1%)
- BULLISH: Trading below Wall St target ($100.96)
- NEUTRAL: Bottoming setup forming (50/100) — watch for confirmation
- CAUTION: 5-day price weakness (-6.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$88.00 -
$92.07
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$83.86
Resistance Level
$92.95
Current Trend
Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
25.69
Wall Street Target
$100.96
(+16.4%)
Revenue Growth (YoY)
13.6%
Earnings Growth (YoY)
-25.4%
Profit Margin
15.4%
Valuation Discount vs History
-0.9% cheaper
PE vs Historical
25.7 vs 26.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.9%
(market-implied from PE analysis)
1-Year Target
$85.99
(-1%)
2-Year Target
$85.22
(-2%)
3-Year Target
$84.45
(-3%)
3-Yr Target (if PE normalizes)
(PE: 26→26)
$86.78
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 25.7, Growth: 12.6%)
$123.89
(+43%)
Base:
(SPY PE: 20.2, Growth: 12.6%)
$97.27
(+12%)
Bear:
(PE: 17.1, Growth: 12.6%)
$82.68
(-5%)
📈
Valuation based on Current Earnings
Forward PE: 25.64 | Forward EPS (Implied): $3.38
Bull Case
$104.77
(+21%)
Analyst growth 15.0%, PE expands to 26.9
Base Case
$86.77
(0%)
Market implied 0.0%, PE stable at 25.6
Bear Case
$66.38
(-24%)
Severe decline -15.0%, PE contracts to 23.1
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 25.7 to 26.4
Stabilization Target:
$89.17
(+2.8%)
PE Expansion Potential:
+2.8%
Share & Embed Analysis
Last updated: September 11, 2026 1:40 PM ET
Data refreshes hourly during market hours. Next update: 2:40 PM
Data refreshes hourly during market hours. Next update: 2:40 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EW showing a specific setup today?
Insider Activity (6 Months)
1
Buys
4
Sells
Net
INSIDERS SELLING
Recent Transactions
Scott B Ullem
SELL
13000 shares
2026-04-09
Daniel J Lippis
SELL
1019 shares
2026-04-06
Donald E Bobo Jr
SELL
22680 shares
2026-04-02
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$63 | 49 HOLD |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 40 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$105 | 52 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 41 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 41 HOLD |
Advanced EW Option Strategies
Professional options setups generated by AI based on today's EW price and gamma walls.
